000 01134 a2200313 4500
005 20250517141426.0
264 0 _c20170515
008 201705s 0 0 eng d
022 _a1179-1950
024 7 _a10.1007/s40265-017-0706-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGeloneze, Bruno
245 0 0 _aGlucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain-Adipocyte Axis.
_h[electronic resource]
260 _bDrugs
_cApr 2017
300 _a493-503 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdipocytes
_xdrug effects
650 0 4 _aAnimals
650 0 4 _aBrain
_xdrug effects
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aGlucagon-Like Peptide-1 Receptor
_xmetabolism
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadministration & dosage
650 0 4 _aGlucagon-Like Peptide-1 Receptor Agonists
700 1 _ade Lima-Júnior, José Carlos
700 1 _aVelloso, Lício A
773 0 _tDrugs
_gvol. 77
_gno. 5
_gp. 493-503
856 4 0 _uhttps://doi.org/10.1007/s40265-017-0706-4
_zAvailable from publisher's website
999 _c26909855
_d26909855